Results 11 to 20 of about 1,979,548 (395)

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.

New England Journal of Medicine, 2019
BACKGROUND Experimental and clinical evidence support the role of inflammation in atherosclerosis and its complications. Colchicine is an orally administered, potent antiinflammatory medication that is indicated for the treatment of gout and pericarditis.
J. Tardif, S. Kouz, D. Waters, O. Bertrand, R. Diaz, A. Maggioni, F. Pinto, R. Ibrahim, H. Gamra, G. Kiwan, C. Berry, J. López-Sendón, P. Ostadal, W. Koenig, D. Angoulvant, J. Grégoire, M. Lavoie, M. Dubé, D. Rhainds, Mylène Provencher, L. Blondeau, Andreas Orfanos, P. L’allier, M. Guertin, F. Roubille   +24 more
semanticscholar   +3 more sources

Complete Revascularization with Multivessel PCI for Myocardial Infarction.

New England Journal of Medicine, 2019
BACKGROUND In patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) of the culprit lesion reduces the risk of cardiovascular death or myocardial infarction.
S. R. Mehta, D. Wood, Robert F. Storey, R. Mehran, Kevin R. Bainey, Helen Nguyen, Brandi Meeks, G. di Pasquale, J. López-Sendón, D. Faxon, L. Mauri, S. Rao, L. Feldman, P. Steg, Á. Avezum, T. Sheth, N. Pinilla-Echeverri, R. Moreno, G. Campo, B. Wrigley, S. Kedev, A. Sutton, R. Oliver, J. Rodés‐Cabau, G. Stanković, R. Welsh, S. Lavi, Warren J. Cantor, Jia Wang, J. Nakamya, S. Bangdiwala, John A. Cairns   +31 more
semanticscholar   +3 more sources

PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION

New England Journal of Medicine, 2002
J. Oss, W. O. Z. Areba, W. J. Ackson, H. E. K. Lein, D. A. J. W. Ilber, D. A. S. C. Annom, J. Ames, P. Aubert, S. T. L. H. Iggins, M. B. Rown, M. A. L. A. Ndrews   +10 more
semanticscholar   +3 more sources

Signaling pathways and targeted therapy for myocardial infarction

Signal Transduction and Targeted Therapy, 2022
Although the treatment of myocardial infarction (MI) has improved considerably, it is still a worldwide disease with high morbidity and high mortality.
Qing Zhang, Lu Wang, Shiqi Wang, Hongxin Cheng, Lin Xu, G. Pei, Yang Wang, Chenying Fu, Yangfu Jiang, Chengqi He, Q. Wei   +10 more
semanticscholar   +1 more source

Acute Myocardial Infarction after Laboratory‐Confirmed Influenza Infection

New England Journal of Medicine, 2018
J. Kwong, K. Schwartz, M. Campitelli, Hannah Chung, N. Crowcroft, T. Karnauchow, K. Katz, D. Ko, A. McGeer, D. McNally, D. Richardson, L. Rosella, A. Simor, M. Smieja, G. Zahariadis, J. Gubbay   +15 more
semanticscholar   +3 more sources

Left ventricular function and coronary microcirculation in patients with mild reduced ejection fraction after STEMI

BMC Cardiovascular Disorders, 2022
Background The characteristics of heart failure (HF) with mildly reduced ejection fraction (EF) (HFmrEF) overlap with those of HF with reduced EF (HFrEF) and HF with preserved EF (HFpEF) and need to be further explored.
Yuliang Ma, Lan Wang, Wenying Jin, Tiangang Zhu, Jian Liu, Hong Zhao, Jing Wang, Mingyu Lu, Chengfu Cao, Bailin Jiang   +9 more
doaj   +1 more source

Treatment of Patients with Myocardial Infarction in Modern Conditions of a Regional Vascular Center

Неотложная медицинская помощь, 2022
The article highlights the problem of providing care for patients with acute coronary syndrome, given the high myocardial infarction (mi) morbidity and mortality among the youth population.
I. M. Kuzmina, N. A. Muradyan, M. V. Parkhomenko   +2 more
doaj   +1 more source

Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study

The Lancet, 2021
Background COVID-19 is a complex disease targeting many organs. Previous studies highlight COVID-19 as a probable risk factor for acute cardiovascular complications.
I. Katsoularis, Osvaldo Fonseca-Rodríguez, P. Farrington, K. Lindmark, A. Fors Connolly   +4 more
semanticscholar   +1 more source

Abnormal inter-ventricular diastolic mechanical delay in patients with ST-segment elevation myocardial infarction

BMC Cardiovascular Disorders, 2023
Background This study aimed to investigate the ventricular mechanical relaxation pattern and its clinical influence in patients with ST-segment elevation myocardial infarction (STEMI).
Wenying Jin, Chao Yu, Lan Wang, Yuliang Ma, Dan He, Tiangang Zhu   +5 more
doaj   +1 more source

Cardiogenic Shock After Acute Myocardial Infarction: A Review.

Journal of the American Medical Association (JAMA), 2021
Importance Cardiogenic shock affects between 40 000 and 50 000 people in the US per year and is the leading cause of in-hospital mortality following acute myocardial infarction.
Marc D. Samsky, D. Morrow, A. Proudfoot, J. Hochman, H. Thiele, S. Rao   +5 more
semanticscholar   +1 more source